Gold-MF Tablet is a combination medication containing Montelukast 10 mg and Fexofenadine 120 mg, formulated to provide effective relief from allergic conditions. Montelukast, a leukotriene receptor antagonist, works by blocking substances called leukotrienes that cause inflammation, bronchoconstriction, and mucus production in the airways, making it particularly useful in the management of asthma and allergic rhinitis. Fexofenadine, a second-generation antihistamine, selectively inhibits peripheral H1 receptors, thereby reducing symptoms such as sneezing, nasal congestion, runny nose, and itching associated with seasonal allergic rhinitis and chronic urticaria. The synergistic action of these two agents offers comprehensive control of allergy symptoms by targeting multiple pathways involved in the allergic response. Gold-MF Tablet is indicated for patients requiring combined therapy for allergic rhinitis, asthma prophylaxis, and chronic idiopathic urticaria. It is generally well tolerated, with a low incidence of sedation due to the non-sedating profile of Fexofenadine and the favorable safety profile of Montelukast. Dosage should be as prescribed by a healthcare professional, considering patient-specific factors. This combination therapy enhances patient compliance by reducing pill burden while providing effective symptom management.